Radiopharmaceutical formulations, their method of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 51/12 (2006.01) A61K 51/04 (2006.01)

Patent

CA 2044812

Radiopharmaceutical formulations for complexes comprising at least one radionuclide complexed with a ligand, or its physiologically-acceptable salts thereof, especially 153samarium-ethylenediaminetetramethylene- phosphonic acid, which optionally contains a divalent metal ion, e.g. calcium, and is frozen, thawed, and then administered by injection. Alternatively, the radiopharmaceutical formulations must contain the divalent metal and are frozen only if the time before administration is sufficiently long to cause concern for radiolysis of the ligand.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Radiopharmaceutical formulations, their method of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Radiopharmaceutical formulations, their method of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiopharmaceutical formulations, their method of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1617327

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.